Skip to main content
. 2023 Jan 19;72(4):496–510. doi: 10.2337/db22-0696

Table 1.

Cohort details

Trait Population cohort Mean age, years Female, % Sample size, n Study participants, n Control participants, n PMID
BMI GIANT/UK Biobank 55.5/56.9* 54.0/54.2* 681,275 30124842
WHR GIANT/UK Biobank 55.5/56.9* 54.0/54.2* 694,649 30239722
Hypertension UK Biobank 56.9* 54.2* 463,010 54,358 408,652 GWAS ID: ukb-b-12493a
T2D DIAGRAM/GERA/UK Biobank 54.1/63.3/56.9* 50.1/59.0/54.2* 655,666 61,714 593,952 30054458
FG MAGIC 50.9 47.7 133,010 22885924
CKD CKDGen 54.0 50.0 625,219 64,164 561,055 31152163
UACR CKDGen 57.0 54.4 547,361 31511532
MA CKDGen 57.0 53.0 54,116 54,116 26631737
eGFR creatinine CKDGen 54.0 50.0 567,460 31152163

All participants were of European descent. MAGIC, Meta-analyses of Glucose and Insulin-Related Traits Consortium; PMID, PubMed Identifier; WHR, waist-to-hip ratio.

*

Study-specific characteristics were not available for all UK Biobank data and were extrapolated from data available.

a

Output from Medical Research Council Integrative Epidemiology Unit GWAS pipeline analysis using Phesant-derived variables from UK Biobank, version 2 (https://doi.org/10.5523/bris.pnoat8cxo0u52p6ynfaekeigi). DIAGRAM, Diabetes Genetics Replication and Meta-analysis; GERA, Genetic Epidemiology Research on Aging; CKDGEN, Chronic Kidney Disease Genetics; MRC-IEU, Medical Research Council Integrative Epidemiology Unit.